71.3
Corvus Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
43.7
FY23:
28.0
FY24:
54.4
FY25:
58.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
38.1
FY22:
24.6
FY23:
17.6
FY24:
14.5
FY25:
12.9
Total assets
Change from FY21 to FY25
millions USD
FY21:
109
FY22:
68.2
FY23:
45.6
FY24:
68.9
FY25:
71.1
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
9.69
FY22:
10.8
FY23:
6.87
FY24:
35.4
FY25:
9.38
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.60
FY22:
1.37
FY23:
0
FY24:
0.94
FY25:
0.53
(positive)
Change from FY21 to FY25
millions USD
FY21:
97.2
FY22:
56.1
FY23:
38.7
FY24:
32.6
FY25:
61.2
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
109
FY22:
68.2
FY23:
45.6
FY24:
68.9
FY25:
71.1
All amounts in millions USD